Antibiotic Treatment for Enterobacter cloacae Complex Cystitis
Rationale for Antibiotic Selection
- The Infectious Diseases Society of America recommends fluoroquinolones as an optimal choice for simple cystitis due to Enterobacter cloacae complex, given their excellent in vitro activity, with ciprofloxacin MIC ≤0.06 and levofloxacin MIC ≤0.12 1
- The use of fluoroquinolones is also supported by their ability to be dose-adjusted for renal impairment, such as a GFR of 28 mL/min, without losing efficacy, and their role in carbapenem-sparing, preserving ertapenem and meropenem for potential future resistant infections 1, 2
Antibiotic Dosing Recommendations
- The recommended dose of ciprofloxacin is 250 mg PO every 24 hours for 7 days, adjusted for GFR <30 mL/min, or levofloxacin 250 mg PO every 48 hours for 7 days, also adjusted for GFR <30 mL/min 3
Why Other Options Are Less Suitable
- Carbapenems, such as ertapenem and meropenem, are excessive for simple cystitis and should be reserved for severe infections or carbapenem-resistant Enterobacterales, as their use can promote resistance 1, 2, 4
- Aminoglycosides, such as tobramycin, carry significant toxicity risks, including nephrotoxicity and ototoxicity, especially in patients with renal impairment, and require careful monitoring 1, 5, 6, 7
Treatment Duration and Monitoring
- The standard treatment duration for uncomplicated cystitis in elderly patients is 7 days of therapy 3
- Patients should be monitored for symptom resolution, renal function, and adverse effects, including fluoroquinolone-associated tendinopathy, QT prolongation, and CNS effects 3